Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.15 USD
Change Today 0.00 / 0.00%
Volume 738.1K
PPHM On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce Allan Chabner M.D.

Medical and Scientific Advisor,Peregrine Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 45 board members in 3 different organizations across 9 different industries.

See Board Relationships


Dr. Bruce Allan Chabner, M.D., is an Advisor of Thomas, McNerney & Partners and focuses on investments in Oncology. Dr. Chabner serves as Scientific Advisor of Lumicell, Inc. Dr. Chabner serves as Medical and Scientific Advisor at Peregrine Pharmaceuticals Inc. Dr. Chabner has been an Associate Director of Clinical Science at the Dana-Farber/Harvard Cancer Center since 1999, which includes the Massachusetts General Hospital, Brigham & Women's Hospital, Dana-Farber Cancer ...

Read Full Background

Corporate Headquarters*

14282 Franklin Avenue
Tustin, California 92780

United States

Phone: 714-508-6000
Fax: 714-838-5817

Board Members Memberships*



MD 1965
Harvard Medical School
BA 1961
Yale College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.15 USD 0.00


J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Philippe Archinard Ph.D.Chairman and Chief Executive Officer
Transgene SA
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at